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Background: Enteroaggregative Escherichia coli (EAEC) causes diarrhea, malnutrition and poor growth in children.
Human breast milk decreases disease-causing bacteria by supplying nutrients and antimicrobial factors such as
lysozyme. Goat milk with and without human lysozyme (HLZ) may improve the repair of intestinal barrier function
damage induced by EAEC. This work investigates the effect of the milks on intestinal barrier function repair,
bacterial adherence in Caco-2 and HEp-2 cells, intestinal cell proliferation, migration, viability and apoptosis in IEC-6
cells in the absence or presence of EAEC.
Methods: Rat intestinal epithelial cells (IEC-6, ATCC, Rockville, MD) were used for proliferation, migration and
viability assays and human colon adenocarcinoma (Caco-2, ATCC, Rockville, MD) and human larynx carcinoma
(HEp-2, ATCC, Rockville, MD) cells were used for bacterial adhesion assays. Goats expressing HLZ in their milk were
generated and express HLZ in milk at concentration of 270 μg/ml . Cells were incubated with pasteurized milk from
either transgenic goats expressing HLZ or non-transgenic control goats in the presence and absence of EAEC strain
042 (O44:H18).
Results: Cellular proliferation was significantly greater in the presence of both HLZ transgenic and control goat milk
compared to cells with no milk. Cellular migration was significantly decreased in the presence of EAEC alone but
was restored in the presence of milk. Milk from HLZ transgenic goats had significantly more migration compared to
control milk. Both milks significantly reduced EAEC adhesion to Caco-2 cells and transgenic milk resulted in less
colonization than control milk using a HEp-2 assay. Both milks had significantly increased cellular viability as well as
less apoptosis in both the absence and presence of EAEC.
Conclusions: These data demonstrated that goat milk is able to repair intestinal barrier function damage induced
by EAEC and that goat milk with a higher concentration of lysozyme offers additional protection.
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Diarrheal-causing bacteria can damage intestinal barrier
function [1]. Repair of damaged intestinal epithelial cells
as a result of bacterial infection requires migration of vi-
able cells adjacent to the site of the damage to cover the
area and then cellular proliferation to replace the lost/
damaged cells in order to restore normal absorptive and
digestive function [1,2]. The process of cell renewal in
the intestine therefore involves proliferation, migration,
differentiation, apoptosis and necrosis, all of which are
related to nutritional status [3,4].
Bacteria can secrete virulence factors and/or adhere to
intestinal cells and prevent cellular proliferation and mi-
gration, as well as apoptosis and necrosis, four important
functions required during the tissue repair process [1].
This is particularly detrimental in young children suffer-
ing from diarrhea as diarrheal diseases are a persistent
risk factor for malnutrition in many parts of the devel-
oping world [5,6]. Damage to the intestinal epithelium
leads to a decreased absorptive surface area and less
availability of nutrients for growth and development
[3,7]. Diarrheal illnesses account for over 1.5 million
deaths worldwide each year with bacteria such as enter-
oaggregative Escherichia coli (EAEC) being one of the
main causes [8,9]. This type of bacteria can cause growth
impairment, malnutrition and cognitive defects even in
children not having active diarrhea [7,10]. The pathogen-
esis underlying the morbidity associated with EAEC is
likely due to damage to intestinal barrier function result-
ing in reduced digestion and absorption of nutrients,
altered cell permeability and immune and inflammatory
responses [10-12]. However, many questions about the
mechanisms remain unanswered.
Oral rehydration solution and breastfeeding are
commonly recommended as interventions for diarrheal
illnesses [3]. Oral rehydration solution can supply elec-
trolytes to combat the dehydration associated with diar-
rhea and breast milk can supply key nutrients such as
protein and fat as well as several innate antimicrobial
proteins such as lysozyme that are thought to help con-
tribute to a healthier gastrointestinal tract [13,14]. One
approach to contribute to these current therapies for
diarrhea could be the administration of goat milk in gen-
eral and milk containing enhanced concentrations of
lysozyme. Goat is a common source of protein world-
wide in the form of both meat and milk. In terms of
milk, goat milk is often more tolerable to humans with
sensitivities to cows’ milk due to differences in protein
and fat composition and structure [15]. For instance, the
amino acid composition of goats’ milk is closer to
human milk than is cow milk and the fat globules are
smaller in goat milk than in cow milk with both factors
contributing the greater digestibility of goat milk com-
pared to cow milk.Concentration of lysozyme in human milk is 1600-
3000 times greater than it is in the milk of common
dairy animals such as goats and cows [16]. Due to
physiological differences, it is not possible to increase
the amount of lysozyme in ruminant milk by breeding
and selection. We have generated transgenic dairy goats
that express human lysozyme (HLZ) in their milk at
68 % the concentrations normally found in human milk
[17,18]. The milk displays antimicrobial activity both
in vitro and in vivo [19,20] and positively impacts the
state of the intestine upon consumption by animal mod-
els [21,22]. We hypothesize that the consumption of
goat milk and goat milk containing lysozyme could help
protect and/or recover damaged intestinal epithelium
resulting from bacterial infection and report here the ef-
fect of the milks on bacterial adherence and intestinal
cell proliferation, migration, viability and apoptosis in
the presence of EAEC, a common diarrheal pathogen.
Methods
Cell culture
Rat intestinal epithelial cells (IEC-6, ATCC, Rockville,
MD) were used for proliferation, migration and viability
assays and human colon adenocarcinoma (Caco-2,
ATCC, Rockville, MD) and human larynx carcinoma
(HEp-2, ATCC, Rockville, MD) cells were used for bac-
terial adhesion assays. The IEC-6 cells were cultured at
37°C in 5 % CO2 in Dulbecco’s modified Eagle medium
(DMEM, GIBCO, Grand Island, NY) containing 5 %
heat-inactivated fetal bovine serum, 10 mg bovine insu-
lin (SIGMA, St. Louis, MO), 50 U/ml penicillin and
50 μg/ml streptomycin (GIBCO, Grand Island, NY). This
cell line comprising intestinal epithelial cells from jejunal
crypts of normal rats is commonly used for studies in-
volving intestinal recovery [23]. Caco-2 cells were cul-
tured at 37°C in 5 % CO2 in DMEM with 10 % fetal
bovine serum, 100 U/ml penicillin and 100 μg/ml
streptomycin, non-essential amino acids and sodium
pyruvate (GIBCO). Caco-2 cells are frequently used as
models of intestinal epithelium as their differentiated
monolayers mimic the top of the crypt and base of intes-
tinal villi [24]. The HEp-2 cells were used to standardize
the bacterial adhesion assays [25]. Cells were cultured at
37°C in 5 % CO2 in minimal essential medium (MEM,
GIBCO, Grand Island, NY) containing 10 % fetal bovine
serum, 100 U/ml penicillin and 100 μg/ml streptomycin.
Milk
Goats expressing HLZ in their milk were generated as
previously described [17] and express HLZ in milk at
concentration of 270 μg/ml [18]. Milk was collected
from HLZ transgenic and non-transgenic control goats
at the UC Davis Goat Facility of the same breed, parity
and stage of lactation. Milk of each type was pooled into
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were taken and stored at -20°C prior to analysis. Milk
was diluted 1:5, 1:20 and 1:40 in DMEM media without
glutamine for all assays. All animals were housed and
cared for under AAALAC-approved conditions.
E. coli strain
EAEC strain 042 (O44:H18) was kindly provided by
Dr. James P. Nataro from the University of Virginia and
was used for all assays. This strain was isolated from a
child with diarrhea and is considered a standard EAEC
strain capable of causing diarrhea in humans [26]. The
bacteria were grown on blood agar plates for 18-24 hours
then two colonies were diluted in 1 ml DMEM and ab-
sorbance at 600 nm recorded. This value became the
reference for the standardization of the dilutions required
to reach the desired concentration (CFU/ml) of bacteria
for use in each assay.
Cell proliferation assay
Cellular proliferation in the presence of HLZ transgenic
and non-transgenic control goat milk was determined
using IEC-6 cells (passages 23-27) as previously
described [27]. Cells were grown to confluence and then
transferred to 96-well plates at a concentration of 4 x
104 cells/ml. Cells were incubated for 48 hours, to ap-
proximately 70 % confluence, then the media were
removed and replaced with DMEM without glutamine
containing 100 μl of HLZ transgenic or control milk at
dilutions of 1:5, 1:20 and 1:40. After 24 hours of incuba-
tion, 10 μl of the tetrazolium salt WST-1 (4-[3-(4-iodo-
phenyl)-2 H-5tetrazolio]-1-3-benzene disulfonate) was
added to each well and incubated for 2-4 hours. WST-1
can be cleaved by mitochondrial dehydrogenase to form
formazan, thus the amount of formazan is proportional
to the number of metabolically active cells in culture.
Formazan concentrations were quantified using an
ELISA reader at 450 nm (reference range 420-480 nm).
Migration assay
The ability of HLZ transgenic and non-transgenic
control goat milk to impact cellular migration in the
presence and absence of bacteria was determined using
IEC-6 cells as previously described [27]. Cells (passages
23-27) were grown to confluence as described above and
then transferred to a 12-well plate at a concentration of
2.4 x 105 cells/ml. After 72 hours of growth, cells were
incubated with mitomycin C (5 μg/ml) for 15-
30 minutes to arrest proliferation. Cells were washed
and media replaced with 500 μl DMEM. The monolayer
was scratched with a sterile blade to drag the cells to
one edge of the well. All wells were then washed twice
with DMEM and then incubated in 1 mL of DMEM
without glutamine containing HLZ transgenic or controlgoat milk at dilutions of 1:5, 1:20 and 1:40 in the absence
and presence of EAEC-042 at a concentration of 2.5 x
105 CFU/ml. Cells were incubated for 24 hours, washed
with HBSS buffer to remove un-adhered bacteria then
observed under an inverted microscope at 10X magnifi-
cation and photographed. The number of cells migrating
across the scratch line was counted using Image-Pro
Plus (Media Cybernetics, Inc, Bethesda, MD) and
calculated based on the surface area of the plate as
adapted from McCormack et al. 1992 [23] and Brito
et al. 2005 [27].
Flow cytometry analysis
The effect of HLZ transgenic and non-transgenic control
goat milk on the distribution of live, apoptotic and dead
cells in the presence of bacteria was determined using
IEC-6 cells. Cells (passages 23-27) were grown to conflu-
ence as described above then plated in 12-well plates at
a concentration of 106 cells/ml [27] and incubated for
24 hours. Media was removed; cells washed and 1 ml of
DMEM without glutamine containing HLZ transgenic
or control goat milk at 1:5, 1:20 and 1:40 dilutions and
2.5 x 105 CFU/ml EAEC-042 was added. After 24 hours
of incubation, media was removed and reserved and cells
were trypsinized and added to the reserved media. The
cell suspension (135 ml) was incubated with 5 ml of 7-
amino-actinomycin (ADD) to stain necrotic cells and
10 ml of Annexin-V-PE to detect apoptotic cells by
binding to externalized phosphatidylserine. After 20 min-
utes of incubation on ice, the samples were analyzed by
flow cytometry (EasyCyte, Guava Technologies, USA)
with red and yellow filters.
Bacterial adhesion
The ability of EAEC-042 to adhere to intestinal cells in
the presence of HLZ transgenic and control goat milk
was determined using Caco-2 cells. Cells (passages 45-
49) were seeded into 24-well plates at a concentration of
5 x 105 cells per well and differentiated for a period of
14 days. The media was then replaced with glutamine-
free DMEM containing HLZ transgenic and non-
transgenic control goat milk at dilutions of 1:5, 1:20 and
1:40 and 2.5 x 105 CFU/ml of EAEC-042. After 1.5 hours
of incubation, non-adherent cells were removed by
washing with HBSS buffer and then lysed with 1 %
Triton-X 100. A total of 100 μl of the lysate was spread
on MacConkey agar plates and colonies quantified by
counting after 24 hours of incubation at 37°C [28]. As
the standard test cell line for EAEC adherence, HEp-2
cells (passage 8) were used to confirm EAEC adherence
ability. Cells were placed in 8-well glass slides at a con-
centration of 5 x 104 cells/ml. After 24 hours of incuba-
tion with the monolayer at approximately 50 %, the
media was removed and replaced with 400 μl of HLZ
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1:20 and 1:40 dilutions prepared in DMEM without glu-
tamine and 0.2 x 102 CFU/ml of EAEC-O42. After
3 hours of incubation at 37°C, the cells were washed and
then stained with May-Grunwald Giemsa and photo-
graphed under the microscope.
Statistical analysis
All assays were performed in triplicate and data reported
as the mean ± SEM (standard error of the mean). Data
were compared using nonparametric multivariate ana-
lysis ANOVA followed by the Bonferroni test using
GraphPad Prism software (version 4.01). P values less
than 0.05 were considered significant.
Results
Proliferation
Cellular proliferation was significantly greater in the
presence of both transgenic and control goat milk at
both the 1:5 and 1:20 dilutions compared to cells with
no milk (Figure 1). Control milk at a 1:5 dilution had
significantly more proliferation than transgenic milk at
the 1:20 and 1:40 dilutions (P < 0.001). Transgenic milk
at a 1:5 dilution had significantly more proliferation than
the highest dilution (1:40) of control milk (P < 0.001).
Migration
The migration of IEC-6 cells was not significantly
impacted by the presence of transgenic or control goat
milk in the absence of bacteria compared to media alone
(Figure 2a). Transgenic milk at a 1:40 dilution had sig-
nificantly more migration than did control goat milk at
the lowest dilution of 1:5 (P < 0.01). In the presence of
bacteria (EAEC-042), migration was significantly lowerFigure 1 HLZ and control goat milk enhance IEC-6
proliferation. Proliferation of IEC-6 cells after 24 hours of incubation
with milk from HLZ transgenic or non-transgenic control goats at
dilutions of 1:5, 1:20 and 1:40. HLZ and control milk was significantly
different from glutamine free DMEM medium (DMEM Gln-), *P< 0.05;
*** P< 0.001.compared to cells without bacteria when incubated in
media alone (P < 0.001) but significantly higher when
incubated with HLZ transgenic or control milk
(Figure 2b). Milk from HLZ transgenic goats at a 1:20
dilution had significantly more migration compared to
control milk at both 1:20 (P < 0.001) and 1:40 (P < 0.05)
dilutions and HLZ milk at the highest dilution (1:40)
had significantly more migration than any of the control
milk dilutions (P < 0.001).
Adhesion
There was a significant reduction in the adhesion of
EAEC-042 to Caco-2 cells in the presence of both milks
(Figure 3). There were no significant differences between
control and HLZ milk. In assays using HEp-2 cells, some
qualitative differences could be seen between the milk
types with transgenic milk having less colonization
(Figure 4).
Cellular viability
Both HLZ transgenic and non-transgenic control goat
milk significantly increased cellular viability in the ab-
sence and presence of EAEC-042 (Figure 5a). There was
a correlating effect on viability with transgenic milk at
the highest dilution (1:40) having the lowest viability.
The percentage of cells in apoptosis and necrosis were
also significantly reduced both in the absence and pres-
ence of EAEC-042 (Figures 5b and 5c, respectively). As
with viability, there was a correlation between dilution
and effect with the more diluted milk having more apop-
totic and dead cells.
Discussion
Morbidity and mortality from diarrheal illnesses remains
a burden worldwide. While not able to prevent diarrhea,
oral rehydration solution can reverse the fluid loss and
dehydration responsible for a majority of the deaths due
to diarrhea and remains the main treatment for this con-
dition [29]. More recent work has demonstrated that
supplementation with micronutrients such as zinc, glu-
tamine and alanyl-glutamine can improve outcomes [30-
33]. However, the mechanisms involved in these biologic
effects remain poorly defined. As a potential alternative
or addition to oral rehydration therapy, we report here
the impact of goat milk with and without increased con-
centrations of the human milk antimicrobial protein
lysozyme on intestinal barrier function in vitro.
We conducted several assays which demonstrated the
mitigation of the effects of EAEC with both goat milk
and goat milk containing increased concentrations of
lysozyme. In the absence of injury, both HLZ transgenic
and control goat milk stimulated cellular proliferation in
IEC-6 cells compared to cells with no milk supplementa-
tion. Milk is known to be beneficial to growth and these
Figure 2 HLZ and control goat milk improve cellular migration in the presence of EAEC. Migration of IEC-6 cells after 24 hours of
incubation with milk from HLZ transgenic or non-transgenic control goats at dilutions of 1:5, 1:20 and 1:40 in the absence (A) and presence (B) of
EAEC-042 (2.5 x 105 CFU/ml) (**P< 0.01; *** P<0.001).
Figure 3 HLZ and control goat milk decrease bacterial
adhesion. Number of colony forming units of EAEC 042 (2.5 x
105 CFU/ml starting concentration) that adhered to Caco-2 cells after
1.5 hours of incubation with milk from HLZ transgenic and non-
transgenic control goats at dilutions of 1:5, 1:20 and 1:40 (*** P<0.001).
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ficial to intestinal cell proliferation. Both protein and fat
are required nutrients for proper cellular functioning
and it is likely that the presence of these ‘extra’ nutrients
contributed to the proliferation of the intestinal cells in
culture. These data also indicate that the presence of
lysozyme in milk does not directly enhance proliferation
in its own. It should be noted that these assays con-
ducted with milk without fat resulted in no differences
(data not shown) pointing to the presence of the fat as
an important component.
When cell injury was induced by the scraping of the
cell monolayer, the presence of milk did not significantly
improve migration in the absence of bacteria, however,
in the presence of EAEC-042 milk significantly improved
cell migration with HLZ transgenic milk performing bet-
ter than control goat milk. Nutrients in the milk, par-
ticularly the fat, could be acting to prevent the EAEC
from associating with the intestinal cells thus allowing
Figure 4 Bacterial adhesion in HEp-2 cells or in the media their self as indicated by the black arrow. (A) EAEC 042 (0.2 x 102 UFC/mL);
EAEC 042 plus milk from non-transgenic control goats at a (B) 1:5, (C) 1:20 and (D) 1:40 dilution; EAEC 042 plus milk from HLZ transgenic goats at
a (E) 1:5, (F) 1:20 and (G) 1:40 dilution. 1000X magnification.
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tent of short chain fatty acids (caprylic, capric and
caproic) that are important in reversing poor dietary in-
take and intestinal disorders [34] and have been found
to act as antimicrobial agents [35,36]. The enhancedeffect by the lysozyme-containing milk from transgenic
animals over non-transgenic control milk may be due to
the antimicrobial activity of lysozyme. Previous work has
demonstrated that there were no significant differences
in the overall amount of fat in HLZ milk compared to
Figure 5 HLZ and control goat milk improve cellular viability. Flow cytometry analysis was conducted to determine the percentage effect of
HLZ or control milk on (A) living IEC-6 cells in the absence and presence of EAEC-042; (B) apoptotic IEC-6 cells in the absence and presence of
EAEC-042; and (C) necrotic IEC-6 cells in the absence and presence of EAEC-042. The IEC-6 cells were incubated for 24 hours in HLZ transgenic or
non-transgenic control goat milk at dilutions of 1:5, 1:20 and 1:40 in the absence or presence of EAEC-042 (2.5 x105 CFU/ml) (*** P< 0.001).
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the two milks differ only in the presence of lysozyme
[37]. The HLZ milk has been shown to have antimicro-
bial activity against several microorganisms including
E. coli both in vitro [19] and at the level of the intestine
[20,21]. However, purified lysozyme alone or added to
control milk was not as efficacious an antimicrobial
agent as the HLZ milk itself [19], indicating that the
in vivo-produced HLZ is more potent. It is therefore
likely that lysozyme is exerting antimicrobial activity to
reduce the number of EAEC present, although this could
not be quantified with this assay. Upon intestinalinfection, certain bacteria can adhere to the intestinal
wall and cause damage to the intestinal epithelium.
Thus, the maintenance of the epithelial barrier is essen-
tial for proper functioning and prevention of the entry
of pathogenic bacteria leading to an inflammatory re-
sponse [38]. Both control and transgenic goat milk sig-
nificantly reduced bacterial adhesion with HLZ milk
offering no advantage over control milk. In this assay,
cells were incubated with milk for only 1.5 hours, likely
too little time for lysozyme to act in a significant anti-
microbial fashion. The mechanism of pathogenesis of
EAEC infection involves the adherence of EAEC-042 to
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herence fimbriae (AAF), secretion of toxins and mucosal
inflammation by the induction of interleukin 8 (IL-8) re-
lease [39]. IL-8 plays an important role in the pathogen-
esis of EAEC, as it recruits neutrophils to the intestinal
epithelial mucosa causing destruction of the epithelium
and promoting fluid secretion [40]. This may be related
to atrophy of the villi with reduced digestion and ab-
sorption of nutrients, one of the mechanisms that could
explain weight loss in affected malnourished children.
While HLZ milk offered no distinct advantage over con-
trol milk in this assay, previous work in vivo has demon-
strated increased villi height and expression of the anti-
inflammatory cytokine TGF-β upon consumption of
HLZ milk indicating that the milk has a protective effect
on the intestinal epithelium [21,22] and combined with
this data suggests a likely beneficial clinical impact on
EAEC infection.
Evidence of altered intestinal barrier function in the
presence of EAEC-042 was seen as there was a reduction
in IEC-6 viability accompanied by an increase in apop-
tosis (2 times greater than control) and necrosis (5 times
greater than control). When supplemented with milk
from HLZ transgenic and non-transgenic control goats,
these effects were mitigated. Again, the nutrients in the
milk may be protecting the cells from the effects of the
bacteria and enhancing their viability. Further studies
are required to elucidate the mechanisms involved. Cell
viability of IEC-6 cells with induced oxidative damage
was increased by the addition of human colostrum, but
not cow milk or infant formulas, and the increase was
attributed to the polyamine spermine reducing the oxi-
dative stress [41]. Polyamines are small cationic mole-
cules that are found in human milk and are required for
intestinal growth and development [42]. Lysozyme also
carries a net positive charge and is a relatively small pro-
tein (14 kDa) and it is likely that properties of lysozyme
other than its antimicrobial function are contributing to
the effect of lysozyme-rich milk. Further work is
required to dissect out the role of lysozyme on these
various aspects of gut barrier function.Conclusions
This study addressed the implications of milk consump-
tion at the level of the intestine, in which much is un-
known about the role of milk on the intestinal
epithelium. Results of these in vitro assays demonstrate
that goat milk can counteract the effects of EAEC on
cell renewal and repair and intestinal cell barrier func-
tion and that goat milk containing higher concentrations
of lysozyme offers additional protection. More studies
are warranted regarding the mechanism of action of
milk and lysozyme on intestinal function with hopes thatthis could be an additional approach to help fight
diarrhea.
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